Clinical Trial Update: Aripiprazole and Resistant Postpartum Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aripiprazole for resistant postpartum depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Postpartum Depression | Phase 3 | Status: COMPLETED